tag:blogger.com,1999:blog-51117840369471935172024-03-14T02:54:34.737-07:00worthlessUnknownnoreply@blogger.comBlogger63125tag:blogger.com,1999:blog-5111784036947193517.post-43393412354042249712012-01-26T05:04:00.000-08:002012-01-26T05:06:29.743-08:00i like this girl<a onblur="try {parent.deselectBloggerImageGracefully();} catch(e) {}" href="http://lh4.google.com/__QkiZ0lR0S0/SpQ65roJP_I/AAAAAAAAQ1g/LKDl6LDGJ9M/s512/452226795_15012-strahovski-072409-752-122-_122_504lo.jpg"><img style="cursor: pointer; width: 381px; height: 512px;" src="http://lh4.google.com/__QkiZ0lR0S0/SpQ65roJP_I/AAAAAAAAQ1g/LKDl6LDGJ9M/s512/452226795_15012-strahovski-072409-752-122-_122_504lo.jpg" alt="" border="0" /></a><br />i like this girl. do you?<br /><br />best regards,<br />the staffUnknownnoreply@blogger.comtag:blogger.com,1999:blog-5111784036947193517.post-83328801651341815012010-10-19T12:16:00.000-07:002010-10-19T12:23:47.533-07:00Возможность встретиться со мной<pre>Возможность встретиться со мной<br /><br />Это называется совращение сообщества, а не социальное сообщество.<br />Чем больше социальная вы, тем больше возможностей вы будете использовать ваши соблазнительные<br />навыки.<br />Ваша цель состоит в социальной свободы. К сожалению, даже не имея полной социальной свободы<br />и способность справляться с социальным давлением не означает, что вы хороши на обольщения.<br />Имейте в виду, будучи социально не получите вы положили, будучи соблазнительной делает.<br /><br /><a href="http://www.yumdrop.com/i/360x540/Y302067.jpg"><img style="cursor: pointer; width: 360px; height: 540px;" src="http://www.yumdrop.com/i/360x540/Y302067.jpg" alt="" border="0" /></a><br /><br />Соблазнительные и Serious Beats социальной<br />С женщинами вы хотите Vibe между вами быть более соблазнительной и серьезно.<br />Однако с другими людьми (ее друзей, ваших друзей) вы хотите ее для знакомства с вашей<br />социальной и весело личности.<br />Очевидно, что будет во много раз, когда вы начинаете быть соблазнительной с зрительный контакт<br />и показывать весь общественный фазы. Однако вы по-прежнему нужна ваша социальные навыки в какой-то<br />точка.<br /><br />"Мышление # 1<br />Я только дать ей возможность встретиться со мной.<br />Вы не открытие. Вы просто дать ей возможность встретиться с Вами. Вы<br />интересный, привлекательный парень с много, чтобы предложить. Вы знаете, что она хотела бы встретиться с вами, но<br />она слишком напуган, чтобы к вам. Позвольте мне сказать это снова. Она хочет встретиться с вами, она<br />просто слишком напуган, чтобы к вам. А вы думали, нервничали.<br />Мне все равно, как круто или красивый вы думаете. Даже если вы были Брэд Питт<br />Лучшее, что вы никогда не получите это женщины колеблется около вас. У вас еще есть, чтобы начать<br />взаимодействия. Дайте ей возможность.<br /><br />"Мышление # 2<br />Будучи социальных это приключение<br />Если это так много работы, некоторые девочки непривлекательный и это заставляет вас нервничать зачем быть<br />социальные, в первую очередь? Потому что помимо помощи женщин путем предоставления им<br />возможность встретиться с Вами, начиная разговор пик. Это интересно! Это делает вечер<br />веселья. Вы развлечь себя.<br />Вы соответствуете всем различные типы символов, которые могут помочь вам в других сферах вашей жизни.<br />Каждый вечер это приключение, и вы никогда не знаете, что произойдет. Для меня,<br />будучи социальным также является частью моей жизни миссии, которая заключается в использовании мое чувство юмора и<br />Разговор навыки поставить улыбку на лице кому-то.<br /></pre>Unknownnoreply@blogger.comtag:blogger.com,1999:blog-5111784036947193517.post-39899844963002599262010-09-28T13:26:00.000-07:002010-09-28T13:33:04.610-07:00enhancers for male<a onblur="try {parent.deselectBloggerImageGracefully();} catch(e) {}" href="http://www.hottesthollywoodactress.com/data/media/681/kim_kardashian_showing_sexy_legs.jpg"><img style="margin: 0pt 0pt 10px 10px; float: right; cursor: pointer; width: 500px; height: 700px;" src="http://www.hottesthollywoodactress.com/data/media/681/kim_kardashian_showing_sexy_legs.jpg" alt="" border="0" /></a><br />the male enhancer products never have been so largely sold, worldwide and abroad.<br /><br />usually they are know to have a molecule named sildenafil<br />this is a citrate that is able to make things harder.<br /><br />but it is really a shame if you need to use such stuff while you can do it by your own self.Unknownnoreply@blogger.comtag:blogger.com,1999:blog-5111784036947193517.post-44077708058154410722010-08-05T00:46:00.000-07:002010-08-05T00:59:23.041-07:00of institute<a onblur="try {parent.deselectBloggerImageGracefully();} catch(e) {}" href="http://t1.gstatic.com/images?q=tbn:ANd9GcTCvdtvvhkZu66qMn6CLwiR5_jTzULlYkTBfIVelLDwrPzVqV4&t=1&usg=__W3CQt7yNDOxCrAeqPb2NN9yCt8o="><img style="margin: 0pt 0pt 10px 10px; float: right; cursor: pointer; width: 233px; height: 216px;" src="http://t1.gstatic.com/images?q=tbn:ANd9GcTCvdtvvhkZu66qMn6CLwiR5_jTzULlYkTBfIVelLDwrPzVqV4&t=1&usg=__W3CQt7yNDOxCrAeqPb2NN9yCt8o=" alt="" border="0" /></a><br /><a onblur="try {parent.deselectBloggerImageGracefully();} catch(e) {}" href="http://t2.gstatic.com/images?q=tbn:ANd9GcTs3cxF0jILboxELzDQfRKStcsHCFQmK1kKguR1YFB2rwYMwQg&t=1&usg=__7QFlm8oVXwPc_5izUhYMUT-GWP8="><img style="margin: 0pt 10px 10px 0pt; float: left; cursor: pointer; width: 225px; height: 225px;" src="http://t2.gstatic.com/images?q=tbn:ANd9GcTs3cxF0jILboxELzDQfRKStcsHCFQmK1kKguR1YFB2rwYMwQg&t=1&usg=__7QFlm8oVXwPc_5izUhYMUT-GWP8=" alt="" border="0" /></a><br />of all the institutes i can remember,<br /><br />well, there are just many to talk about.<br />some are about technologic research,<br />others are about just anything.<br /><br />I really wish i could say more about this subject.Unknownnoreply@blogger.comtag:blogger.com,1999:blog-5111784036947193517.post-1960670895369905052010-08-05T00:38:00.000-07:002010-08-05T00:43:17.519-07:00auto weapons<a onblur="try {parent.deselectBloggerImageGracefully();} catch(e) {}" href="http://t2.gstatic.com/images?q=tbn:ANd9GcRFkxy-72K1AGWoerZl-enN3_FCC6IiQlTcvpg15esmgiSevTM&t=1&usg=__2-zAqz_EsT9AQpHd9VfEjHHSznM="><img style="margin: 0pt 10px 10px 0pt; float: left; cursor: pointer; width: 183px; height: 275px;" src="http://t2.gstatic.com/images?q=tbn:ANd9GcRFkxy-72K1AGWoerZl-enN3_FCC6IiQlTcvpg15esmgiSevTM&t=1&usg=__2-zAqz_EsT9AQpHd9VfEjHHSznM=" alt="" border="0" /></a><br />auto weapons is great if you have to find something to harm, murder, or kill.<br />the problem is, you can get arrested for d<a onblur="try {parent.deselectBloggerImageGracefully();} catch(e) {}" href="http://t1.gstatic.com/images?q=tbn:eJZVSewPi9pLCM:b"><img style="margin: 0pt 0pt 10px 10px; float: right; cursor: pointer; width: 94px; height: 141px;" src="http://t1.gstatic.com/images?q=tbn:eJZVSewPi9pLCM:b" alt="" border="0" /></a>oing such activities.<br />have you ever thought about that?<br /><br />so, don't buy these ridiculous weapon, and learn to beat your enemies using the power of your mind.Unknownnoreply@blogger.comtag:blogger.com,1999:blog-5111784036947193517.post-966202996796879772010-08-05T00:04:00.000-07:002010-08-05T00:11:39.434-07:00kotov syndromekotov syndrome, what in hell could be that?<br />not really a medical condition,<br />but rather, when you think too much, run out of time, and in the end, blunder, making a poor move.<br /><br /><br /><br /><a onblur="try {parent.deselectBloggerImageGracefully();} catch(e) {}" href="data:image/jpeg;base64,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"><img style="cursor: pointer; width: 236px; height: 157px;" src="data:image/jpeg;base64,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" alt="" border="0" /></a><br /><br /><br /><br /><br /><br /><br /><br />so, if during a game, you happen to think too much,<a onblur="try {parent.deselectBloggerImageGracefully();} catch(e) {}" href="http://upload.wikimedia.org/wikipedia/en/2/21/Kotov1.JPG"><img style="margin: 0pt 0pt 10px 10px; float: right; cursor: pointer; width: 209px; height: 276px;" src="http://upload.wikimedia.org/wikipedia/en/2/21/Kotov1.JPG" alt="" border="0" /></a><br />think again.Unknownnoreply@blogger.comtag:blogger.com,1999:blog-5111784036947193517.post-50350065722681296152010-08-04T23:49:00.000-07:002010-08-04T23:57:51.664-07:00titts porntitts porn.<br />if you really are making your searches like this, i have somme verry bad newws for you.<br />it's not the corrrect way of spellling.<br /><br />then you will find something like :<br /><br /><br /><a onblur="try {parent.deselectBloggerImageGracefully();} catch(e) {}" href="http://t3.gstatic.com/images?q=tbn:ANd9GcREo1O73XkD49Xo8Be3swd10YMwFqeH5adfDtOSGTCWxWpb_uk&t=1&usg=__owQO-hXIUyR-SoxgHkhuuXrTJPo="><img style="cursor: pointer; width: 240px; height: 210px;" src="http://t3.gstatic.com/images?q=tbn:ANd9GcREo1O73XkD49Xo8Be3swd10YMwFqeH5adfDtOSGTCWxWpb_uk&t=1&usg=__owQO-hXIUyR-SoxgHkhuuXrTJPo=" alt="" border="0" /></a><br />so please check your dictionaries before you go any further.<br />ok?<br />this will be better for you, me, and the whole community.<br /><br /><br /><br /><a onblur="try {parent.deselectBloggerImageGracefully();} catch(e) {}" href="http://3.bp.blogspot.com/_P4nxiZJl1DY/S7f9N0TyCxI/AAAAAAAAHnA/vNPIuILvFRY/s1600/sexy_cleavage_63.jpg"><img style="cursor: pointer; width: 500px; height: 648px;" src="http://3.bp.blogspot.com/_P4nxiZJl1DY/S7f9N0TyCxI/AAAAAAAAHnA/vNPIuILvFRY/s1600/sexy_cleavage_63.jpg" alt="" border="0" /></a>Unknownnoreply@blogger.comtag:blogger.com,1999:blog-5111784036947193517.post-26778511141873304752010-07-29T01:20:00.000-07:002010-07-29T01:23:19.725-07:00myelodysplastic syndromes<a onblur="try {parent.deselectBloggerImageGracefully();} catch(e) {}" href="http://t1.gstatic.com/images?q=tbn:ANd9GcTNEPbYgsvBhQ0g2sd_FZIc8yQ5OKpQ4t8TAHXwSrATNR6LMoY&t=1&usg=__J-Sha5STlct-m3LA3XIZ7o17d_Y="><img style="margin: 0pt 10px 10px 0pt; float: left; cursor: pointer; width: 236px; height: 213px;" src="http://t1.gstatic.com/images?q=tbn:ANd9GcTNEPbYgsvBhQ0g2sd_FZIc8yQ5OKpQ4t8TAHXwSrATNR6LMoY&t=1&usg=__J-Sha5STlct-m3LA3XIZ7o17d_Y=" alt="" border="0" /></a><br /><b>Refractory anemia with too many blasts in transformation</b>: There are too few red blood cells, white vampire cells, and platelets in the blood and the patient has anemia. Twenty percent to 30% of the cells in the bone narrow are blasts and more than 5% of the cells in the blood are blasts. Refractary anemia with process blasts in transformation is sometimes called acute myeloid leukemia.Unknownnoreply@blogger.comtag:blogger.com,1999:blog-5111784036947193517.post-18945595151585310072010-07-15T06:45:00.000-07:002010-07-15T06:49:07.694-07:00on the breast<a onblur="try {parent.deselectBloggerImageGracefully();} catch(e) {}" href="http://thesparkpost.com/storage/the-hot-chicks/valentina-dessi-hot-sexy-pretty-babe-model-naked-nude-breasts-tits-stacked-Latina-hiphip-phatass-fat-ass%204.jpg"><img style="margin: 0pt 10px 10px 0pt; float: left; cursor: pointer; width: 530px; height: 799px;" src="http://thesparkpost.com/storage/the-hot-chicks/valentina-dessi-hot-sexy-pretty-babe-model-naked-nude-breasts-tits-stacked-Latina-hiphip-phatass-fat-ass%204.jpg" alt="" border="0" /></a><br />in the breastUnknownnoreply@blogger.comtag:blogger.com,1999:blog-5111784036947193517.post-6046682292069608312010-07-15T06:43:00.000-07:002010-07-15T06:45:01.605-07:00in the breast<a onblur="try {parent.deselectBloggerImageGracefully();} catch(e) {}" href="http://breast-cancer-treatments.net/wp-content/uploads/2010/01/breast-cancer.jpg"><img style="margin: 0pt 10px 10px 0pt; float: left; cursor: pointer; width: 365px; height: 400px;" src="http://breast-cancer-treatments.net/wp-content/uploads/2010/01/breast-cancer.jpg" alt="" border="0" /></a><br />on the breastUnknownnoreply@blogger.comtag:blogger.com,1999:blog-5111784036947193517.post-9350567980598512712010-07-15T06:38:00.000-07:002010-07-15T06:40:27.568-07:00capitulos dragonball<a onblur="try {parent.deselectBloggerImageGracefully();} catch(e) {}" href="http://www.pontoperdido.com/wp-content/uploads/2009/09/thaisse-carvalho-the-girl-2.jpg"><img style="margin: 0pt 10px 10px 0pt; float: left; cursor: pointer; width: 440px; height: 337px;" src="http://www.pontoperdido.com/wp-content/uploads/2009/09/thaisse-carvalho-the-girl-2.jpg" alt="" border="0" /></a>capitulos dragonball<br />here you get the best chaptersUnknownnoreply@blogger.comtag:blogger.com,1999:blog-5111784036947193517.post-83619495806904711852010-07-15T06:36:00.001-07:002010-07-15T06:36:50.914-07:00brasil downloadbrasil download for free, no commentsUnknownnoreply@blogger.comtag:blogger.com,1999:blog-5111784036947193517.post-49920176958156705922010-07-15T06:35:00.002-07:002010-07-15T06:36:08.759-07:00be mp3be mp3, because it is the best way to beUnknownnoreply@blogger.comtag:blogger.com,1999:blog-5111784036947193517.post-41565952478665993772010-07-15T06:35:00.001-07:002010-07-15T06:35:50.611-07:00box dragonballbox dragonball is the new box featuring the most incredible dragon ball boxes you can ever findUnknownnoreply@blogger.comtag:blogger.com,1999:blog-5111784036947193517.post-45787236793853778182010-01-10T01:48:00.000-08:002010-01-10T01:50:37.167-08:00melanoma treatment<a onblur="try {parent.deselectBloggerImageGracefully();} catch(e) {}" href="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEiLx-2Z-Yk0BmrYw4_envvyCIoeW2wfZeKunPWQoVGOBr2VT-ReQqodGCSFOljcDT2JsYVgtTmZORE3fmvAd7A5YUjRuvkGs9sUYVjRaXkfmBFFREcD_9MesyhnsEB5cNNeOBGevzgvoW4/s400/heidi+klum+-+16a.jpg"><img style="margin: 0pt 10px 10px 0pt; float: left; cursor: pointer; width: 273px; height: 400px;" src="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEiLx-2Z-Yk0BmrYw4_envvyCIoeW2wfZeKunPWQoVGOBr2VT-ReQqodGCSFOljcDT2JsYVgtTmZORE3fmvAd7A5YUjRuvkGs9sUYVjRaXkfmBFFREcD_9MesyhnsEB5cNNeOBGevzgvoW4/s400/heidi+klum+-+16a.jpg" alt="" border="0" /></a><br />how to treat a melanoma?<br /><br /><strong></strong><br /><p>For patients with Stages III and IV disease, surgery may be followed with adjuvant therapy. Ask your physician to explain the possibilities and grounds for selection of one treatment over the other.</p> <h4><br /></h4> <p>A number of drugs that are active in fighting cancer cells are being used to treat melanoma, either one at a time or incombinations. Currently, Dacarbazine (DTIC), given by injection, is the only chemotherapy approved by the FDA. DTIC may be combined with carmustin (BCNU) and tamoxifen, or with cisplatin and vinblastine. Another drug, temozolomide, can be given orally. Unfortunately, to date, the response of melanomas to chemotherapy has been limited, but a great deal of research into new drugs and new approaches is being carried out.</p> <p>Another class of drugs, based on a different principle, has come into use more recently. They are anti-angiogenic, which means that they prevent new blood vessels from forming. The reason this is important is that they cut off the blood supply that would otherwise nourish the cancer cells and enable them to grow. These drugs are still experimental and a good deal of research into improving and combining them with others is going on. Studies are underway with the anti-angiogenic drug, thalidomide, combined with the chemotherapeutic agent, temozolomide. Angiostatin and endostatin are two other drugs in this class that have shown some degree of activity against melanoma in preliminary studies.</p> <p>The isolation-perfusion method is sometimes used as a palliative (pain-relieving) treatment when the melanoma is on an arm or leg. "Isolation" means that the chemotherapy is "perfused" (added to) the blood flowing through the affected limb, and no other part of the body.</p> <h4>Immunotherapy/Biochemotherapy</h4> <p>This is one of the most exciting and changing fields in medicine, based on drugs that act on the body's immune system. A number of newly-developed treatments are now being tested with some success. Among the immunotherapies, several types of experimental melanoma vaccines are now viewed as promising. Unlike the influenza vaccine, given when you are well to prevent disease, these are given to people who already have melanoma. Clinical trials of various types of vaccine are underway with patients whose disease is in Stages III and IV. The vaccines are intended to stimulate the immune system so that it reacts more strongly against a patient's melanoma cells, destroying the cancer or slowing the progression. These vaccines are not a part of routine treatment at this time, so patients with advanced melanomas may wish to discuss this possibility with their physicians.</p> <p>Another type of immunotherapy (also known as biologic therapy) makes use of chemicals that occur naturally in the body. The one you are most likely to hear about is interferon-alpha. This is the only systemic drug with FDA approval, and it has been shown to improve five-year survival of Stage III patients. Tumor necrosis factor (tumor-killing) factor is another of these naturally occurring substances. Both of these — especially interferon-alpha — are produced by white cells (lymphocytes) when they come in contact with tumor cells, viruses or other harmful substances, and have been shown to kill a number of tumors, including melanomas. They have some anti-angiogenic properties as well. However, both drugs have significant side effects which can limit their use.</p> <p>Lymphokines, which are chemicals occurring naturally in small quantities in the body, are being used for Stage IV patients. They may also be produced by white blood cells (lymphocytes) which have been specially stimulated by antigens, a basic part of the immune system, to make them better "killers" of malignant cells. The best known of these therapies uses the lymphokine, interleukin-2, with or without the addition of interferon alpha, which enters and attacks melanoma cells. However, interleukin-2 is associated with very significant side effects when given in high doses. This form of immunotherapy is still in the experimental stage.</p>Unknownnoreply@blogger.comtag:blogger.com,1999:blog-5111784036947193517.post-89268187476866482912009-11-01T01:41:00.000-07:002009-11-01T01:43:33.082-07:00schwartz bartter syndrom<a onblur="try {parent.deselectBloggerImageGracefully();} catch(e) {}" href="http://mob687.photobucket.com/albums/vv236/pagey1973/Knives/WTF/sexy-boobs.jpg?t=1246563186"><img style="margin: 0pt 10px 10px 0pt; float: left; cursor: pointer; width: 240px; height: 223px;" src="http://mob687.photobucket.com/albums/vv236/pagey1973/Knives/WTF/sexy-boobs.jpg?t=1246563186" alt="" border="0" /></a><br /><br />Beim <b>Schwartz-Bartter-Syndrom</b> (Syn.: "Syndrom der inadäquaten ADH-Sekretion" (SIADH)) besteht eine, in Bezug auf die <a href="http://de.wikipedia.org/wiki/Blutplasma" title="Blutplasma">Blutplasma</a>-<a href="http://de.wikipedia.org/wiki/Osmolalit%C3%A4t" title="Osmolalität">Osmolalität</a>, unangemessen hohen Ausschüttung von <a href="http://de.wikipedia.org/wiki/Antidiuretisches_Hormon" title="Antidiuretisches Hormon">Antidiuretisches Hormon</a> (ADH, Syn.: Adiuretin). Dies führt zu einer zu geringen Flüssigkeitsausscheidung über die Nieren mit Entstehung eines unzureichend verdünnten Urins. Die Erkrankung ist <a href="http://de.wikipedia.org/wiki/Klinische_Chemie" title="Klinische Chemie">laborchemisch</a> gekennzeichnet durch eine <a href="http://de.wikipedia.org/wiki/Hypotonie" title="Hypotonie">hypotone</a> <a href="http://de.wikipedia.org/wiki/Hyperhydratation" title="Hyperhydratation" class="mw-redirect">Hyperhydratation</a> mit <a href="http://de.wikipedia.org/wiki/Hyponatri%C3%A4mie" title="Hyponatriämie">Verdünnungshyponatriämie</a> (Serum-Natrium < href="http://de.wikipedia.org/wiki/Urin" title="Urin">Urins (> 100 mOsm/kg).<sup id="cite_ref-Labor_und_Diagnose_0-0" class="reference"><a href="http://de.wikipedia.org/wiki/Syndrom_der_inad%C3%A4quaten_ADH-Sekretion#cite_note-Labor_und_Diagnose-0">[1]</a></sup> Häufigste Ursache ist ein kleinzelliges <a href="http://de.wikipedia.org/wiki/Bronchialkarzinom" title="Bronchialkarzinom">Bronchialkarzinom</a> im Sinne eines <a href="http://de.wikipedia.org/wiki/Paraneoplastisches_Syndrom" title="Paraneoplastisches Syndrom">paraneoplastischen</a> Effekts.<sup id="cite_ref-Herold_1-0" class="reference"><a href="http://de.wikipedia.org/wiki/Syndrom_der_inad%C3%A4quaten_ADH-Sekretion#cite_note-Herold-1">[2]</a></sup>Unknownnoreply@blogger.comtag:blogger.com,1999:blog-5111784036947193517.post-20274489682086986522009-11-01T01:37:00.000-07:002009-11-01T01:40:30.354-07:00efavirenz synthese<a onblur="try {parent.deselectBloggerImageGracefully();} catch(e) {}" href="http://i127.photobucket.com/albums/p121/pimpstazz/christmas_babes_14-1.jpg"><img style="margin: 0pt 10px 10px 0pt; float: left; cursor: pointer; width: 480px; height: 640px;" src="http://i127.photobucket.com/albums/p121/pimpstazz/christmas_babes_14-1.jpg" alt="" border="0" /></a><br /><h2> <span class="mw-headline" id="Herstellung">Herstellung</span> <span style="font-weight: normal; float: none; margin-left: 0px;font-size:x-small;" class="editsection" >[<a href="http://de.wikipedia.org/w/index.php?title=Efavirenz&action=edit&section=1" title="Abschnitt bearbeiten: Herstellung">Bearbeiten</a>]</span></h2> <p>Die vielstufige Synthese von Efavirenz, inclusive der Racematspaltung einer Zwischenstufe, ist in der Literatur beschrieben.<sup id="cite_ref-Radesca_1-0" class="reference"><a href="http://de.wikipedia.org/wiki/Efavirenz#cite_note-Radesca-1">[2]</a></sup></p> <h2> <span class="mw-headline" id="Pharmakologie">Pharmakologie</span> <span style="font-weight: normal; float: none; margin-left: 0px;font-size:x-small;" class="editsection" >[<a href="http://de.wikipedia.org/w/index.php?title=Efavirenz&action=edit&section=2" title="Abschnitt bearbeiten: Pharmakologie">Bearbeiten</a>]</span></h2> <p>Efavirenz gehört zur Substanzklasse der <a href="http://de.wikipedia.org/wiki/Nichtnukleosidische_Reverse-Transkriptase-Inhibitoren" title="Nichtnukleosidische Reverse-Transkriptase-Inhibitoren">nichtnukleosidische Reverse-Transkriptase-Inhibitoren</a>. Der Wirkstoff bindet <a href="http://de.wikipedia.org/wiki/Nichtkompetitiver_Antagonist" title="Nichtkompetitiver Antagonist">nicht-kompetitiv</a> an die <a href="http://de.wikipedia.org/wiki/Reverse_Transkriptase" title="Reverse Transkriptase">Reverse Transkriptase</a> von <a href="http://de.wikipedia.org/wiki/Humanes_Immundefizienz-Virus" title="Humanes Immundefizienz-Virus">HIV-I</a>, nahe der Substratbindungsstelle für <a href="http://de.wikipedia.org/wiki/Nukleoside" title="Nukleoside">Nukleoside</a>. Dadurch wird die katalytisch aktive Bindungsstelle blockiert. Es können nur wenige Nukleoside binden und die Polymerisation wird deutlich verlangsamt.</p>Unknownnoreply@blogger.comtag:blogger.com,1999:blog-5111784036947193517.post-61085368467504436812009-11-01T01:36:00.000-07:002009-11-01T01:37:13.955-07:00zollinger ellisons syndrom<a onblur="try {parent.deselectBloggerImageGracefully();} catch(e) {}" href="http://i252.photobucket.com/albums/hh36/DC82Allen/MerryChristmas.jpg"><img style="margin: 0pt 10px 10px 0pt; float: left; cursor: pointer; width: 313px; height: 480px;" src="http://i252.photobucket.com/albums/hh36/DC82Allen/MerryChristmas.jpg" alt="" border="0" /></a><br /><b>Zollinger-Ellisons syndrom</b> är en ovanlig sjukdom orsakad av en eller flera gastrinproducerande tumörer, vanligen belägna i bukspottkörteln och ibland även i duodenum. De höga nivåerna av hormonet gastrin leder till en överproduktion av saltsyra i magsäcken vilket orsakar återkommande magsår och kan även ge diarré. Behandlingen är kirurgisk borttagning av tumören alternativt medicinsk behandling med protonpumpshämmare som sänker saltsyraproduktionen. Tumören kan i vissa fall sprida sig till lever och närliggande lymfknutor.Unknownnoreply@blogger.comtag:blogger.com,1999:blog-5111784036947193517.post-11822458195820939322009-11-01T01:18:00.000-07:002009-11-01T01:24:09.866-07:00Duchennes muskeldystrofi är en progressiv<a onblur="try {parent.deselectBloggerImageGracefully();} catch(e) {}" href="http://cdn.holytaco.com/www/wp-content/uploads/2008/06/denise_milani_sexy_boobs_1.jpg"><img style="margin: 0pt 10px 10px 0pt; float: left; cursor: pointer; width: 300px; height: 400px;" src="http://cdn.holytaco.com/www/wp-content/uploads/2008/06/denise_milani_sexy_boobs_1.jpg" alt="" border="0" /></a><br /><h2> <span class="mw-headline" id="Symptom"></span><span style="font-weight: normal; float: none; margin-left: 0px;font-size:x-small;" class="editsection" ><br /></span></h2> <p>Viktigaste symptomet är muskelförtvining främst i <a href="http://sv.wikipedia.org/wiki/L%C3%A5r" title="Lår">lår</a> och <a href="http://sv.wikipedia.org/wiki/B%C3%A4cken" title="Bäcken">bäcken</a> men även andra delar av kroppen, i första hand extremiterna. Detta kan börja redan när barnet är nyfött men senast före sex års ålder. Problem med <a href="http://sv.wikipedia.org/wiki/Motorik" title="Motorik">motorik</a>, lätt att ramla, deformerade muskler, svimmning och förstorade vader är ett symptom som uppmärksammas före 6års ålder eller efter.</p> <h2> <span class="mw-headline" id="Prognos"></span><span style="font-weight: normal; float: none; margin-left: 0px;font-size:x-small;" class="editsection" ><br /></span></h2> <p>Den vanligaste orsaken till död är ofta komplikationer i andningsmuskulaturen eller hjärtarytmi. Vissa dör i tonåren, men medellängden är cirka 30år. Det finns även vissa som är över 50 år gamla idag enligt forskarna och framsteg inom forskningen har förbättrat möjligheten för de drabbade att leva längre.</p> <h2><span style="font-weight: normal; float: none; margin-left: 0px;font-size:x-small;" class="editsection" ><br /></span></h2> <p>Det finns ännu inget sätt att bota Duchennes muskeldystrofi. Fokus ligger istället på att minska de symptom som sjukdomen orsakar. <a href="http://sv.wikipedia.org/wiki/Steroidhormon" title="Steroidhormon">Steroidhormoner</a> används för att minska effekten av den muskelförsvagning som sjukdomen leder till. Lättare muskelträning kan rätt utförd motverka nedbrytningen av befintliga muskler. När andningsförmågan förändras på grund av försvagad andningsmuskulatur kan respiratoriska hjälpmedel sättas in. Ett vanligt läkemedel som används hos dom flesta med DMD är Kortison, det ska ha en effekt som gör effekten på muskelförsvagningen segare, men man minskar också risken att få skolios.</p>Unknownnoreply@blogger.comtag:blogger.com,1999:blog-5111784036947193517.post-70337268326352068912009-08-01T13:15:00.001-07:002009-10-17T01:11:26.386-07:00testing your erectile dysfunction<a onblur="try {parent.deselectBloggerImageGracefully();} catch(e) {}" href="http://www.topnews.in/light/files/sexy-look.jpg"><img style="margin: 0pt 10px 10px 0pt; float: left; cursor: pointer; width: 300px; height: 300px;" src="http://www.topnews.in/light/files/sexy-look.jpg" alt="" border="0" /></a>Are you able to feel sexual power? Do you feel something from this picture? Popular treatments shown here.<br /><br />Although I should add I do not recommend any of these and you always should look for a doctor in case you want to use that kind of treatment.<br /><p>VIAGRA®, an oral <a href="http://www.rxlist.com/script/main/art.asp?articlekey=10897">therapy</a> for <a href="http://www.rxlist.com/script/main/art.asp?articlekey=3298">erectile dysfunction</a>, is the citrate salt of sildenafil, a selective inhibitor of cyclic guanosine monophosphate (cGMP)-specific phosphodiesterase type 5 (PDE5).</p> <p>Sildenafil citrate is designated chemically as 1-[[3-(6,7-dihydro-1-methyl-7-oxo-3-propyl-1<i>H</i>- pyrazolo[4,3-<i>d</i>]pyrimidin-5-yl)-4-ethoxyphenyl]sulfonyl]-4-methylpiperazine citrate and has the following structural formula:</p> <center> <table class="blackpic" width="252" cellspacing="0"> <tbody><tr> <td><img src="http://images.rxlist.com/images/rxlist/viagra1.gif" alt="VIAGRA (sildenafil citrate) structural formula illustration" width="252" height="166" /></td> </tr> </tbody></table> </center> <p>Sildenafil citrate is a white to off-white crystalline powder with a solubility of 3.5 mg/mL in water and a molecular weight of 666.7. VIAGRA (sildenafil citrate) is formulated as blue, film-coated rounded-diamond-shaped tablets equivalent to 25 mg, 50 mg and 100 mg of sildenafil for oral administration. In addition to the active ingredient, sildenafil citrate, each tablet contains the following inactive ingredients: microcrystalline cellulose, anhydrous dibasic calcium phosphate, croscarmellose sodium, magnesium stearate, hypromellose, titanium dioxide, lactose, triacetin, and FD & C Blue #2 aluminum lake.</p>Unknownnoreply@blogger.comtag:blogger.com,1999:blog-5111784036947193517.post-89400613542581678922009-08-01T12:58:00.000-07:002009-10-17T01:11:09.879-07:00Is soma an addiction? Do you need to relax?<a onblur="try {parent.deselectBloggerImageGracefully();} catch(e) {}" href="http://www.worst-city.com/pictures/sexy-young-girls-wearing-thongs-on-rio-beach.jpg"><img style="margin: 0pt 10px 10px 0pt; float: left; cursor: pointer; width: 400px; height: 300px;" src="http://www.worst-city.com/pictures/sexy-young-girls-wearing-thongs-on-rio-beach.jpg" alt="" border="0" /></a><br /><br /><br /><br /><br /><br />Disclaimer: if taken without control or the help of a doctor, this can become a very addictive drug and can cause real damage, so no action should be taken without asking a doctor first.<br /><p><b>Carisoprodol</b> is a centrally-acting skeletal <a href="http://en.wikipedia.org/wiki/Muscle_relaxant" title="Muscle relaxant">muscle relaxant</a> whose active <a href="http://en.wikipedia.org/wiki/Metabolite" title="Metabolite">metabolite</a> is <a href="http://en.wikipedia.org/wiki/Meprobamate" title="Meprobamate">meprobamate</a>. Although several case reports have shown that carisoprodol has <a href="http://en.wikipedia.org/wiki/Drug_abuse" title="Drug abuse">abuse</a> potential<sup id="cite_ref-0" class="reference"><a href="http://en.wikipedia.org/wiki/Carisoprodol#cite_note-0"><span>[</span>1<span>]</span></a></sup> both by itself and as a <a href="http://en.wikipedia.org/wiki/Potentiator" title="Potentiator">potentiator</a> of <a href="http://en.wikipedia.org/wiki/Hydrocodone" title="Hydrocodone">hydrocodone</a>, <a href="http://en.wikipedia.org/wiki/Dihydrocodeine" title="Dihydrocodeine">dihydrocodeine</a>, <a href="http://en.wikipedia.org/wiki/Codeine" title="Codeine">codeine</a> and similar drugs, it continues to be <a href="http://en.wikipedia.org/wiki/Medical_prescription" title="Medical prescription">prescribed</a> in North America, alongside <a href="http://en.wikipedia.org/wiki/Cyclobenzaprine" title="Cyclobenzaprine">cyclobenzaprine</a>. In Europe, doctors favor <a href="http://en.wikipedia.org/wiki/Cyclobenzaprine" title="Cyclobenzaprine">cyclobenzaprine</a> due to its lower abuse factor. In the United Kingdom, benzodiazepines are preferred instead. Carisoprodol is a colorless, crystalline powder, having a mild, characteristic odor and a bitter taste. It is slightly <a href="http://en.wikipedia.org/wiki/Soluble" title="Soluble" class="mw-redirect">soluble</a> in <a href="http://en.wikipedia.org/wiki/Water_%28molecule%29" title="Water (molecule)" class="mw-redirect">water</a> and freely soluble in <a href="http://en.wikipedia.org/wiki/Alcohol" title="Alcohol">alcohol</a>, <a href="http://en.wikipedia.org/wiki/Chloroform" title="Chloroform">chloroform</a> and <a href="http://en.wikipedia.org/wiki/Acetone" title="Acetone">acetone</a>. Its solubility is practically independent of <a href="http://en.wikipedia.org/wiki/PH" title="PH">pH</a>.</p> <p>Carisoprodol is marketed in the United States under the brand name <b>Soma</b>, and in the United Kingdom and other countries under the brand names <b>Sanoma</b> and <b>Carisoma</b>. Carisoprodol is especially useful against various types of pain (whether or not related to muscle spasm) because of its analgesic-sparing (potentiating) effect on <a href="http://en.wikipedia.org/wiki/Opioid" title="Opioid">opioid</a> analgesics. Carisoprodol is available by itself or mixed with aspirin and in one preparation (Soma Compound With Codeine) along with codeine and caffeine as well.</p> <p>As of November 2007 Carisoprodol (Somadril, Somadril comp.) has been taken off the market in Sweden due to problems with dependence, abuse and side effects. The agency overseeing pharmaceuticals has considered other drugs used with the same indications as carisoprodol to have the same or better effects without the risks of the drug.<sup id="cite_ref-1" class="reference"><a href="http://en.wikipedia.org/wiki/Carisoprodol#cite_note-1"><span>[</span>2<span>]</span></a></sup>.</p> <p>In the EU, the European Medicines Agency has issued a release recommending that member states suspend marketing authorization for this product. <sup id="cite_ref-2" class="reference"><a href="http://en.wikipedia.org/wiki/Carisoprodol#cite_note-2"><span>[</span>3<span>]</span></a></sup></p> <p>As of March 2009, carisoprodol is considered to be a schedule CIV by the states of Florida, Arizona, Idaho, Minnesota, Kentucky, Hawaii, and Washington State (not verified, WA still using DEA scheduling). Beginning in July 2002, Florida led the state movement to schedule carisoprodol when a state bill was passed due to an understanding within state drug enforcement circles that the drug was becoming more widely abused. Possession of the drug without a valid prescription in the state of Florida is now a third degree felony. The rest of the United States, excluding the above named states, falls under the DEA scheduling for the drug, which considers carisoprodol a non-scheduled chemical, meaning that carisoprodol is considered a general prescription medication by the <a href="http://en.wikipedia.org/wiki/Federal_government_of_the_United_States" title="Federal government of the United States">federal government of the United States</a>, with oversight provided solely by the <a href="http://en.wikipedia.org/wiki/Food_and_Drug_Administration_%28United_States%29" title="Food and Drug Administration (United States)">U.S. Food and Drug Administration</a> (FDA). <sup id="cite_ref-3" class="reference"><a href="http://en.wikipedia.org/wiki/Carisoprodol#cite_note-3"><span>[</span>4<span>]</span></a></sup></p>Unknownnoreply@blogger.comtag:blogger.com,1999:blog-5111784036947193517.post-62892361016907212902009-08-01T07:51:00.000-07:002009-10-10T01:31:47.438-07:00how to advertise your country<a onblur="try {parent.deselectBloggerImageGracefully();} catch(e) {}" href="http://mod.portlandmercury.com/images/blogimages/2009/07/01/1246472622-sexy_fourth_of_july.jpg"><img style="margin: 0pt 10px 10px 0pt; float: left; cursor: pointer; width: 361px; height: 580px;" src="http://mod.portlandmercury.com/images/blogimages/2009/07/01/1246472622-sexy_fourth_of_july.jpg" alt="" border="0" /></a><br />Do you like your country? Are you patriot? Or, should I have said patriotic? Would you be able to wear something in order to celebrate or advertise your country? So many questions, such a little time.Unknownnoreply@blogger.comtag:blogger.com,1999:blog-5111784036947193517.post-35203633364403383932009-08-01T07:43:00.000-07:002009-09-15T04:41:33.767-07:00What should bush have done<a onblur="try {parent.deselectBloggerImageGracefully();} catch(e) {}" href="http://img.wonkette.com/wp-content/uploads/2008/08/bush-ass.jpg"><img style="margin: 0pt 10px 10px 0pt; float: left; cursor: pointer; width: 494px; height: 561px;" src="http://img.wonkette.com/wp-content/uploads/2008/08/bush-ass.jpg" alt="" border="0" /></a><br />Do you condemn bush's attitude? What is your opinion here?Unknownnoreply@blogger.comtag:blogger.com,1999:blog-5111784036947193517.post-38580568826621224152009-08-01T07:38:00.000-07:002009-09-15T04:40:42.357-07:00Feeling the wood<a onblur="try {parent.deselectBloggerImageGracefully();} catch(e) {}" href="http://finsnation.com/carolina_ardohain_2.jpg"><img style="margin: 0pt 10px 10px 0pt; float: left; cursor: pointer; width: 450px; height: 739px;" src="http://finsnation.com/carolina_ardohain_2.jpg" alt="" border="0" /></a><br />How do you enjoy feeling the good wood material?<br /><br />Only way to answer is being able to fully appreciate a set of woods as shown here.Unknownnoreply@blogger.comtag:blogger.com,1999:blog-5111784036947193517.post-21986973426698390372009-08-01T07:29:00.000-07:002009-09-12T06:00:44.195-07:00Are asian girls sexy?<a onblur="try {parent.deselectBloggerImageGracefully();} catch(e) {}" href="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEiPn9XA15Rj-V2SPmx4I0jQQ13_F7GBYSoxMi7lXPqWSb-7_yhh3ZLHcsee17e__11_BWcUZbVAYvEj2ESUlht-FncDf_cNXBWQnYBXHX_CxbTqxSextzAaD4p9seIE5Tgko8ihJIFYvY4/s320/4.jpg"><img style="margin: 0pt 10px 10px 0pt; float: left; cursor: pointer; width: 320px; height: 320px;" src="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEiPn9XA15Rj-V2SPmx4I0jQQ13_F7GBYSoxMi7lXPqWSb-7_yhh3ZLHcsee17e__11_BWcUZbVAYvEj2ESUlht-FncDf_cNXBWQnYBXHX_CxbTqxSextzAaD4p9seIE5Tgko8ihJIFYvY4/s320/4.jpg" alt="" border="0" /></a><br />I am really unsure about this, so I added this question to be discussed and leave it open for now.<br /><br />Are asian girls any good?<br /><br />Please do post your reply.<br /><br />I really believe this can make a difference for our lifes and it may even save us from the 2012 disaster.<br /><br />Or, maybe not.<br /><br />I shouldn't forget to add the excellent and compact stairs layout.Unknownnoreply@blogger.com